Medicare Enrolled
Dr. Shalin Shah, D.O.
Medical Oncology · Brandon, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Shalin Shah is a medical oncology in Brandon, FL, with 19 years in practice. Based on federal Medicare data, Dr. Shah performed 236,234 Medicare services across 4,651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $18,154 from 84 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in FL$ $18,154 industry payments
Medicare Practice Summary
Medicare Utilization ↗236,234
Medicare services
Top 10% in FL for medical oncology
4,651
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,433 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 36,120 | $0 | $2 |
| Iron infusion (Feraheme) | 35,700 | $0 | $4 |
| Iron infusion (Injectafer) | 27,000 | $1 | $3 |
| Anti-nausea injection (aprepitant) | 24,440 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 20,622 | $0 | $12 |
| Pembrolizumab injection (Keytruda) | 19,400 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 12,510 | $6 | $23 |
| Contrast dye for imaging (iodine-based) | 11,616 | $0 | $1 |
| Injection, atropine sulfate, 0.01 mg | 7,500 | $0 | $1 |
| Iron sucrose injection (Venofer) | 6,500 | $0 | $5 |
| Dexamethasone injection (steroid) | 5,470 | $0 | $3 |
| Iron infusion (Monoferric) | 4,600 | $16 | $57 |
| Denosumab injection (Prolia/Xgeva) | 3,780 | $18 | $51 |
| Complete blood count (CBC) with differential | 2,744 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,500 | $1 | $28 |
| Blood draw (venipuncture) | 2,458 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,672 | $96 | $339 |
| Injection, leucovorin calcium, per 50 mg | 1,222 | $3 | $12 |
| Injection, irinotecan, 20 mg | 1,100 | $2 | $177 |
| Anti-nausea injection (ondansetron/Zofran) | 1,008 | $0 | $9 |
| Drug injection, under skin or into muscle | 991 | $10 | $69 |
| Injection, fluorouracil, 500 mg | 944 | $2 | $7 |
| Injection of additional new drug or substance into vein | 831 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 695 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 541 | $21 | $84 |
| Injection, carboplatin, 50 mg | 393 | $2 | $41 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 304 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 292 | $48 | $189 |
| Infusion into a vein for hydration, each additional hour | 279 | $9 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 251 | $1 | $3 |
| Administration of additional new drug or substance into vein, 1 hour or less | 232 | $48 | $178 |
| Office visit, established patient, complex (40-54 min) | 205 | $137 | $474 |
| Office visit, established patient (20-29 min) | 198 | $65 | $239 |
| Infusion, normal saline solution , 1000 cc | 190 | $2 | $7 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 188 | $17 | $59 |
| Administration of chemotherapy into vein, each additional hour | 167 | $21 | $79 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 122 | $122 | $637 |
| Ct scan of chest with contrast | 113 | $53 | $344 |
| Infusion into a vein for hydration, 31-60 minutes | 109 | $24 | $156 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 106 | $401 | $680 |
| Administration of additional new drug or substance into vein using push technique | 103 | $42 | $170 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 103 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 98 | $15 | $56 |
| CT scan of abdomen and pelvis with contrast | 97 | $170 | $550 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 92 | $1,095 | $3,706 |
| New patient office visit (45-59 min) | 88 | $124 | $453 |
| Injection, magnesium sulfate, per 500 mg | 80 | $1 | $2 |
| Automated urinalysis | 62 | $2 | $8 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 60 | $25 | $89 |
| Red blood count, automated test | 56 | $4 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $135 | $562 |
| Injection of drug or substance into vein | 47 | $28 | $156 |
| Red blood count automated, with additional calculations | 38 | $5 | $20 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 35 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 34 | $16 | $56 |
| New patient office visit, complex (60-74 min) | 26 | $167 | $585 |
| CT scan of chest, without contrast | 17 | $46 | $350 |
| Nuclear medicine study whole body with ct scan | 16 | $1,098 | $3,706 |
| Transitional care management services for problem of high complexity | 14 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.2% high complexity
67.3% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,154
Total received (2018-2024)
Avg $2,593/year across 7 years
Top 28% in FL for medical oncology
84
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,702 (70.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,262 (29.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$190 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,414
2023$2,238
2022$2,058
2021$531
2020$557
2019$2,046
2018$7,311
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$5,359
Novartis Pharmaceuticals Corporation
$1,765
Biosense Webster, Inc.
$967
PFIZER INC.
$957
E.R. Squibb & Sons, L.L.C.
$892
Genentech USA, Inc.
$844
Janssen Biotech, Inc.
$617
Gilead Sciences, Inc.
$487
Celgene Corporation
$386
AstraZeneca Pharmaceuticals LP
$378
GENZYME CORPORATION
$344
Merck Sharp & Dohme LLC
$281
Lilly USA, LLC
$265
Amgen Inc.
$234
Pharmacyclics LLC, An AbbVie Company
$222
Daiichi Sankyo Inc.
$221
Merck Sharp & Dohme Corporation
$208
Takeda Pharmaceuticals U.S.A., Inc.
$177
IBA Proton Therapy, Inc.
$169
TerSera Therapeutics LLC
$157
Medtronic, Inc.
$148
GlaxoSmithKline, LLC.
$148
Seagen Inc.
$136
Astellas Pharma US Inc
$132
ABBVIE INC.
$127
Mirati Therapeutics, Inc.
$114
Exelixis Inc.
$110
Tempus AI, Inc
$103
Eisai Inc.
$102
Alexion Pharmaceuticals, Inc.
$100
Seattle Genetics, Inc.
$98
TESARO, Inc.
$96
PharmaEssentia USA Corporation
$76
Bayer Healthcare Pharmaceuticals Inc.
$74
NanoString Technologies, Inc.
$71
Pharmacyclics LLC, an AbbVie Company
$70
JAZZ PHARMACEUTICALS INC.
$68
Regeneron Healthcare Solutions, Inc.
$68
Ipsen Biopharmaceuticals, Inc
$64
Janssen Pharmaceuticals, Inc
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
ImmunoGen, Inc.
$54
Clovis Oncology, Inc.
$54
Kite Pharma, Inc.
$53
Rigel Pharmaceuticals, Inc.
$52
Karyopharm Therapeutics Inc.
$50
EISAI INC.
$49
Telix Pharmaceuticals
$47
ARRAY BIOPHARMA INC
$45
BeiGene USA, Inc.
$44
EMD Serono, Inc.
$43
Incyte Corporation
$39
G1 Therapeutics, Inc.
$38
GE HealthCare
$36
AbbVie, Inc.
$36
Epizyme, Inc.,
$35
SpringWorks Therapeutics, Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$34
AbbVie Inc.
$30
TAIHO ONCOLOGY, INC.
$29
Boston Scientific Corporation
$29
Teva Pharmaceuticals USA, Inc.
$26
Puma Biotechnology, Inc.
$26
Sun Pharmaceutical Industries Inc.
$25
Novo Nordisk Inc
$23
Heron Therapeutics, Inc.
$20
Agios Pharmaceuticals, Inc.
$19
AVEO Pharmaceuticals, Inc.
$19
Myriad Genetic Laboratories, Inc.
$18
Sobi, Inc
$17
CTI BioPharma Corp.
$17
BOSTON SCIENTIFIC CORPORATION
$17
Kyowa Kirin, Inc.
$17
Sumitomo Pharma America, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$16
RECORDATI_RARE_DISEASES_INC.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Array BioPharma Inc.
$13
Supernus Pharmaceuticals, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$12
Shire North American Group Inc
$12
Secura Bio, Inc.
$10
Sirtex Medical Inc
$8
Veracyte, Inc.
$1
Top 3 companies account for 44.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JARDIANCE · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MICRA · MONJUVI · MVASI · Micra · NERLYNX · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · ODOMZO · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · Ozempic · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Pomalyst · Poteligeo · QELBREE · REBLOZYL · RHYTHMIA · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · WATCHMAN FLX · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xolair · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
57
Per 100K population
3.8
County median income
$75,011
Nearest hospital
HCA FLORIDA BRANDON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Shah performed 36,120 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $18,154 from 84 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other medical oncologys in Brandon?
Dr. Shah's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Brandon
Browse medical oncologys in Brandon ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology